Phase 2/3 Study of IGSC, 20% in PIDD
Completed · Phase 2/Phase 3
Conditions studied: Primary Immunodeficiency Diseases (PID)
In brief
The purpose of this study is to develop a 20% subcutaneous (SC) immunoglobulin preparation for the treatment of patients with primary immunodeficiency diseases (PIDD).
Key facts
- Study ID
- NCT01218438
- Run by
- Baxalta now part of Shire
- People needed
- 86
- Starts
- 2013-01-28
- Expected to finish
- 2015-03-13
- Last updated by the study team
- 2021-07-20
Who can join
Age: 2 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California, Irvine — Irvine, California, United States
- IMMUNOe International Research Centers — Centennial, Colorado, United States
- Allergy Associates of the Palm Beaches — North Palm Beach, Florida, United States
- Emory University — Atlanta, Georgia, United States
- Rush University Medical Center — Chicago, Illinois, United States
- Family Allergy and Asthma Research Institute — Louisville, Kentucky, United States
- Children's Hospital New Orleans- LSUHSC School of Medicine — New Orleans, Louisiana, United States
- Midwest Immunology Clinical and Infusion Center — Plymouth, Minnesota, United States
- SSM Cardinal Glennon Children's Medical Center — St Louis, Missouri, United States
- Montefiore Medical Center Division of Allergy/Immunology — The Bronx, New York, United States
- Oklahoma Institute of Allergy and Asthma Clinical Research — Oklahoma City, Oklahoma, United States
- Vital Prospects Clinical Research Institute, PC — Tulsa, Oklahoma, United States
- Dallas Allergy Immunology Research — Dallas, Texas, United States
- Allergy Asthma and Immunology Clinic PA — Irving, Texas, United States
- Rocky Mountain Asthma/Allergy/Immunology — Layton, Utah, United States
- Medical College of Wisconsin — Milwaukee, Wisconsin, United States
- Centre Hospitalier Universitaire (CHU) Sainte-Justine — Montreal, Quebec, Canada
- Montreal Children's Hospital- McGill University health Center — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.